Diabetes is notoriously difficult to control and treat. Typically, patients are given insulin injections and medication, which may lead to side effects like weight gain or loss, low blood sugar, upset stomach, and more. Virta Health has taken stage by storm with its natural approach to helping people control Type 2 diabetes. Its program includes remote monitoring, tracking, and education combined with a ketogenic diet. After raising $65 million in December 2020 and becoming a unicorn, Virta Health just doubled its valuation to $2 billion after closing a Series E round at a whopping $133 million in April 2021. The new funds will be used to expand Virta’s medication-free solution and reach more patients to make diabetes reversal truly mainstream. Virta’s successive financing rounds is not just a testament to the viability of the company’s product, but a sign of growing competition in an industry longing for innovation.